Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
MDR Klebsiella pneumoniae ST307 is a high-risk clone, whose genetic features contribute to its adaptation to hospital environments and the human host. This study describes the emergence and clonal dissemination of K. pneumoniae ST307, recovered during November 2018 to February 2019 in a hospital in Buenos Aires city, which concurrently harbored KPC-3 and NDM-1. These isolates were resistant to all β-lactams and to the ceftazidime/avibactam combination. Molecular studies showed that bla was located in Tn4401a platform, while bla was surrounded upstream by ISKpn14 followed by a partial sequence of ISAba125 and downstream by bleMBL-trpF, located in a 145.5kb conjugative plasmid belonging to the Inc A/C group. The dissemination of K. pneumoniae ST307 isolates co-producing KPC-3 and NDM-1 could lead to a worrisome scenario due to the remarkable features of this clone and its resistance profile.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ram.2022.04.002 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Genomic Characterization of Multidrug-Resistant and ESBL-Producing Isolated from Healthy Rabbits Intended for Human Consumption.
Microorganisms
August 2025
LAQV-REQUIMTE, Department of Chemistry, NOVA School of Science and Technology, Universidade Nova de Lisboa, 1099-085 Caparica, Portugal.
is an important pathogen associated with multidrug resistance and virulence in both human and animal populations. While its prevalence and resistance patterns are well documented in clinical settings, data on in food-producing animals remain scarce. This study aimed to isolate and characterize multidrug-resistant strains from healthy rabbits raised for human consumption, with a focus on antimicrobial resistance genes, plasmid content, and associated mobile genetic elements.
View Article and Find Full Text PDFGenomic Epidemiology of ESBL- and Carbapenemase-Producing Enterobacterales in a Spanish Hospital: Exploring the Clinical-Environmental Interface.
Microorganisms
August 2025
Area of Biochemistry and Molecular Biology, One Health-UR Research Group, Faculty of Science and Technology, Universidad de La Rioja, Madre de Dios 53, 26006 Logroño, Spain.
Antimicrobial resistance (AMR), particularly due to extended-spectrum β-lactamases (ESBLs) and carbapenemases (CPs), poses a critical threat to global health. This study aimed to characterize the molecular epidemiology, resistance profiles, and genomic features of ESBL- and CP-producing and (ESBL/CP-Ec/Kp) isolates from a Spanish hospital (2020-2024) and explore links to environmental reservoirs like white storks foraging at a nearby landfill. A total of 121 clinical Ec/Kp isolates (55 ESBL-Ec, 1 CP-Ec, 35 ESBL-Kp, 17 CP-Kp, 13 ESBL+CP-Kp) underwent phenotypic testing, PCR, and whole-genome sequencing (WGS).
View Article and Find Full Text PDFClinical and genomic insights into persistent carbapenem-resistant Klebsiella pneumoniae bacteremia: risk factors, resistance mechanisms, and treatment challenges.
Biomed J
August 2025
School of Medicine, College of Medicine, Chang Gung University, 333 Taoyuan, Taiwan; Division of Pediatric Infectious Diseases, Departments of Pediatrics, Chang Gung Memorial Hospital, 333 Taoyuan, Taiwan; Molecular Infectious Diseases Research Center, Chang Gung Memorial Hospital, 333 Taoyuan, Taiw
Introduction: Carbapenem-resistant Klebsiella pneumoniae (CRKP) is a major cause of nosocomial infections with high mortality rates. Persistent bacteremia, indicative of treatment failure, poses significant clinical challenges. This study aimed to identify clinical parameters for persistent CRKP bacteremia while exploring microbial and genetic characteristics.
View Article and Find Full Text PDFMeropenem/vaborbactam activity against carbapenem-resistant from catheter-related bloodstream infections.
Front Cell Infect Microbiol
August 2025
Microbiology and Virology, San Gallicano Dermatological Institute IRCCS, Rome, Italy.
Introduction: Carbapenem-resistant (CRKP) poses a significant threat in oncology settings due to its multidrug resistance and ability to form biofilms on indwelling medical devices.
Methods: This study investigated the and activity of meropenem/vaborbactam (MEV) against two CRKP isolates recovered from catheter-related bloodstream infections in patients undergoing orthopedic oncologic surgery.
Results: Whole-genome sequencing identified the isolates as ST101 and ST307, harboring resistance determinants including and , distributed across IncFII and IncFIB plasmid replicons.
ICU environment as a reservoir of KPC-ST307-Klebsiella pneumoniae high-risk clone resistant to ceftazidime-avibactam.
Sci Rep
August 2025
Servicio de Microbiología, Hospital Universitario Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.
We characterized all ceftazidime-avibactam-resistant KPC-producing K. pneumoniae (KPC-Kp) isolates recovered from both patients and environmental samples at the ICU of our hospital in 2020, during the COVID-19 pandemic initiation. Antimicrobial susceptibility testing (Sensititre-EUMDROXF; disk-diffusion) and WGS analysis (Illumina-Novaseq/Miseq; Oxford Nanopore-MinION) were performed.
View Article and Find Full Text PDF